February 22nd, 2010 - Proteros and Axikin reach significant milestones with integrated drug discovery project. — In January 2010, only nine months after having set up the collaboration, rapid progress has been made in discovering and characterizing distinct chemical entities towards a novel therapeutic target for chronic obstructive pulmonary disease (COPD)... Read On...

January 22, 2009 - Axikin Pharmaceuticals Spins Out of Actimis
Axikin Pharmaceuticals, Inc., a startup company dedicated to developing and commercializing small molecule therapeutics for respiratory and inflammatory diseases, today announced a $3 million private placement of its Series A stock. The financing was led by Sanderling Ventures... Read On...